RGM Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

RGM Capital’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-136,338	Closed	-$2.56M	–	21
2021 Q4	$2.56M	Sell	136,338 -1,995,243	-94%	-$53.3M	0.11%	21
2021 Q3	$70M	Buy	2,131,581 +178,404	+9%	+$6.66M	3.43%	16
2021 Q2	$83.3M	Buy	1,953,177 +331,002	+20%	+$12.9M	3.85%	15
2021 Q1	$62.2M	Buy	1,622,175 +448,477	+38%	+$19.1M	2.72%	20
2020 Q4	$51.4M	Buy	1,173,698 +845,425	+258%	+$31.8M	2.24%	21
2020 Q3	$12.9M	Buy	+328,273	New	+$10.6M	0.73%	23
2016 Q1	–	Sell	-1,322,113	Closed	-$20M	–	21
2015 Q4	$20M	Buy	+1,322,113	New	+$19.6M	2.61%	20

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

RGM Capital's CSII Position: Q1 2022 in Review

RGM Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2022, closing a stake of 136,338 shares — an estimated $2.56M sold.

RGM Capital first reported a position in CSII in Q4 2015 and held it in 7 quarters. The position peaked at $83.3M in Q2 2021. 173 funds tracked by Wall St. Rank hold CSII as of Q1 2022.

RGM Capital reported no remaining Cardiovascular Systems, Inc. position as of Q1 2022 after selling out during the quarter.
RGM Capital sold 136,338 Cardiovascular Systems, Inc. shares in Q1 2022, an estimated $2.56M.
RGM Capital first reported a position in Cardiovascular Systems, Inc. in Q4 2015 and held it in 7 quarters.
RGM Capital's Cardiovascular Systems, Inc. position peaked at $83.3M in Q2 2021.
173 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2022.

Based on RGM Capital's 13F filing for Q1 2022, filed 13 May 2022.